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Background: Fewer than one in 10 adolescents with substance use disorders (ASUDs) will receive specialty treatment,
and even fewer will receive treatment designated as evidence-based practice (EBP). Traditional efforts to increase the
utilization of EBP by ASUDs typically focus on practitioners—either in substance use clinics or allied health settings.
Direct-to-consumer (DTC) marketing that directly targets parents of ASUDs represents a potentially complementary
paradigm that has yet to be evaluated. The current study is the first to evaluate the relevance of a well-established
marketing framework (the Marketing Mix) and measurement approach (measurement of perceived service quality
[PSQ]) with parents of ASUDs in need of treatment.
Methods/design: A mixed-methods design is employed across three study phases, consistent with well-established
methods used in the field of marketing science. Phase 1 consists of formative qualitative research with parents (and a
supplementary sample of adolescents) in order to evaluate and potentially adapt a conceptual framework (Marketing
Mix) and measure of PSQ. Phase 2 is a targeted survey of ASUD parents to elucidate their marketing preferences, using
the adapted Marketing Mix framework, and to establish the psychometric properties of the PSQ measure. The survey
will also gather data on parents’ preferences for different targeted marketing messages. Phase 3 is a two-group
randomized controlled trial comparing the effectiveness of targeted marketing messages versus standard clinical
information. Key outcomes will include parents’ ratings of PSQ (using the new measure), behavioral intentions to
seek out information about EBP, and actual information-seeking behavior.
Discussion: The current study will inform the field whether a well-established marketing framework and measurement
approach can be used to increase demand for EBP among parents of ASUDs. Results of this study will have the
potential to immediately inform DTC marketing efforts by professional organizations, federal agencies, clinicians,
and clinical researchers.
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The dissemination and implementation (D&I) of effective
behavioral interventions for adolescents with substance
use disorders (ASUDs) has been recognized as a critical
initiative by legislators, insurers, funding agencies, re-
searchers, and clinicians alike [1]. Relative to adults with
substance use disorders, ASUDs have more rapid progres-
sion from first use to a diagnosable disorder, more binge
episodes, and more co-occurring problems [2,3]. When
left untreated or ineffectively treated, ASUDs often have
persistent problems into adulthood, increasing the risk
of a range of negative long-term outcomes, including
school failure, accidents, criminal involvement, unin-
tended pregnancy, and even death [4]. Fortunately, recent
systematic reviews and meta-analyses have identified
several outpatient interventions that have consistently
been associated with reductions in adolescent substance
use in randomized controlled trials (RCTs) [5-8]. These in-
terventions are commonly recognized as evidence-based
practices (EBPs) and include cognitive behavioral therapy
models (both individual and group), family therapy models
(both behavioral and ecological), and motivational inter-
viewing. Considering that over 80 percent of ASUDs
seek treatment in outpatient settings [9], increasing the
utilization of these EBP models represents a significant
priority for our field and for our nation’s public health.
Prior D&I efforts
Prior efforts to increase EBP utilization can be viewed as
targeting two related, yet distinct, gaps. The first is the
“research-to-practice” or “evidence-to-practice” gap and
pertains to the disparity between those treatment models
with the greatest evidentiary support and those delivered in
practice [10,11]. Attempts to close this gap have predomin-
antly targeted individual clinicians and organizational
systems as deliverers of EBP, with the goal of increasing
the supply of EBP in community settings. Over the past
two decades, recognition of the myriad challenges
bridging the research-to-practice gap has led to an ex-
ponential increase in publications on how to effectively
transfer EBP to community treatment providers, with
topics including: (a) development of conceptual models
and frameworks to guide EBP transfer [12]; (b) identifi-
cation of barriers and facilitators to adapting EBP
[13,14]; (c) assessment of provider and agency interest
in EBP [15]; (d) evaluation of training and roll-out strat-
egies [16-18]; and (e) effectiveness studies testing EBP
delivered under “real-world” circumstances [19]. Add-
itionally, federal agencies have invested significant re-
sources toward promoting the delivery of EBP in routine
clinical practice, such as the Substance Abuse and Mental
Health Services Administration-funded network of
Addiction Technology Transfer Centers and the National
Institute on Drug Abuse-funded Clinical Trials Network.The second gap is the “treatment-seeking” or “unmet
need” gap and refers to the chasm between those indi-
viduals who need treatment and those who actually seek
it [20]. Despite the fact that only about 9 percent of
ASUDs receive any form of specialty treatment [21],
efforts to close this gap have been the focus of signifi-
cantly less research and funding. The principal approach
for targeting the treatment-seeking gap has been a focus
on training allied health professionals and “gatekeepers”
to improve the identification of ASUDs. One common
strategy has been to integrate ASUD assessment and
brief intervention into a variety of allied health-care set-
tings, including primary care offices, emergency depart-
ments, schools, court systems, and detention centers/
prisons. Integration efforts have been promoted through
programs such as universal ASUD screening [22], en-
hanced training in ASUD assessment [23], and co-located
ASUD treatments [24]. Specific approaches to promote
the integration of ASUD services into routine practice
include, but are not limited to, Screening, Brief Inter-
vention, and Referral to Treatment [22] and assertive
outreach models [25].
An important limitation of prior D&I research in the
ASUD field is that it has primarily focused on practi-
tioners—both in specialty and allied health services—as
the target audience of outreach efforts. With the excep-
tion of universal screening initiatives, these efforts have
focused on increasing the supply of EBP in the commu-
nity, without considering whether parents of ASUDs will
demand the services provided. Consequently, prior D&I
initiatives are most likely to benefit ASUDs who seek
services of their own volition or who come into contact
with the treatment system due to a concurrent mental
health, behavioral, or legal problem. As explicated by
Ozechowski and Waldron [25], this approach does not
address approximately 50 percent of ASUDs who do not
have concurrent problems, nor does it address well-
documented barriers to seeking treatment, such as lack
of knowledge about treatment, lack of motivation for
treatment, and a belief that problems can be solved
without help. Thus, there is significant need to develop
new strategies to increase the demand for EBP by par-
ents of ASUDs.
Direct-to-Customer (DTC) marketing: a complementary
approach
DTC marketing, defined as marketing targeted directly
to treatment customers, represents a complementary
paradigm to traditional D&I models. In contrast to
traditional approaches that attempt to “push” EBP to pa-
tients through treatment providers, a DTC approach
attempts to increase awareness of EBP so that customers
will request it and “pull” it through the system. A well-
established framework in the marketing literature is the
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which refer to: Product (or Service), Price, Place, and
Promotion. As presented in Figure 1, each component of
the Marketing Mix reflects a key set of considerations
that need to be addressed before marketing a service.
Recent manuscripts have considered how the Marketing
Mix might apply to the delivery of mental health and
substance use treatment [27,28], but the relevance of the
Marketing Mix has never been assessed with actual
treatment customers. Reflecting this gap in our know-
ledge base, this study aims to test whether the Marketing
Mix can be used as a guiding framework to develop ef-
fective DTC marketing messages for parents of ASUDs.
Although all four elements of the Marketing Mix are
important, scholars in the field of services marketing
(the marketing of professional services) have argued that
the Product (or Service) component is especially vital,
because of the need to understand how customers define
a quality service experience. In a widely cited article,
Berry, Parasuraman, and Zeithaml (pg. 35) asserted that
“service quality has become the great differentiator, the
most powerful competitive weapon most service organi-
zations possess,” and they further argue that “it is the
customer’s definition of quality, not management that
counts” [29]. Services are significantly more difficult to






Figure 1 Marketing mix elements and key questions.intangible, heterogeneous over time and across providers,
and difficult to reproduce; consequently, customers’ sub-
jective perceptions of quality become critically important
predictors of whether customers will actually seek out the
service [29,30]. Over the past 25 years, the Marketing
Science Institute has supported extensive research on cus-
tomer perceptions of service quality [29-37]. Formative
qualitative research in several industry sectors [31,34,38]
led to the development of SERVQUAL [39,40] a question-
naire that evaluates perceived service quality (PSQ) across
five dimensions: Reliability, Responsiveness, Assurance,
Empathy, and Tangibles. The SERVQUAL is widely ac-
cepted as the gold-standard measure of PSQ, having been
used in over 70 service industries across 17 countries
[26,41]. Multiple other measures of PSQ have also been
developed and used in marketing research [42,43].
Benefits of measuring perceived service quality
Prior marketing studies have demonstrated three major
advantages of using measures like the SERVQUAL to
evaluate PSQ. First, use of PSQ measures can establish
the service quality attributes that most strongly predict
behavioral intentions with regard to service selection and
loyalty [33,37]. Such knowledge can potentially be used to
develop targeted marketing messages to increase customer
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administration of PSQ instruments can be used to evalu-
ate whether specific marketing initiatives are effective in
changing customers’ opinions of service [26,30]. Finally,
service providers can periodically use a PSQ questionnaire
to ensure that customers receive consistent, high-quality
service, which can then be used to support specific
marketing claims [26].
To date, PSQ measures have been used to evaluate
health services in a range of settings across multiple
countries, including nursing homes, hospitals, outpatient
medical clinics, and dental clinics [44-50]. However, only
one prior study has used a PSQ questionnaire to evalu-
ate mental health services [50], and no studies have used
one to evaluate SUD services. Moreover, an examination
of prior studies reveal a number of modifications to
extant PSQ questionnaires to increase their relevance to
health services. Focusing on the SERVQUAL, modifica-
tions in prior health-care studies in the United States
have included removing items [45,50], revising items
[45,49,50], and adding new items [49,51]. These modi-
fications have been associated with changes to the
SERVQUAL’s psychometric properties and structure,
with some studies finding that the SERVQUAL had
three or four dimensions [52] and others finding six or
more dimensions [49,51,53]. New quality dimensions
found in more than one study have included “caring”,
“empathy”, and “provider competence”.
An alternative to idiosyncratic, study-specific modifi-
cations is the development of a refined PSQ measure
specifically for the assessment of ASUD services. There
is a precedent for this approach in the marketing litera-
ture. Approximately 10 years ago, the SERVQUAL was
frequently applied to assess ecommerce service transac-
tions, despite a number of theoretical differences be-
tween standard services and online services [54]. The
SERVQUAL developers therefore conducted formative
qualitative research and customer surveys, resulting in a
new measure (the E-S-QUAL) with different items and a
new dimensional structure [55]. Following this precedent,
the current study proposes to use qualitative research andTable 1 Timeline of research activities by study phase
Phase Year 1 Y
1 Focus groups and structured interviews X X X X
Thematic coding and analysis X X
Adaptation of Marketing Mix and PSQ (AIM 1)
2 Survey design, sampling, and implementation
Survey analysis and PSQ validation (AIMS 2–3)
3 Randomized trial of targeted marketing (AIM 4)
Quantitative analysis and results disseminationsurvey methods to create a new PSQ questionnaire for use
with ASUD behavioral treatments.
Specific aims and study phases
As depicted in Table 1, this study has three phases that
address four specific aims. Phase 1 consists of formative
qualitative research in order to evaluate and potentially
adapt a conceptual model (the Marketing Mix) and quan-
titative measure (a PSQ measure based on the SERVQ-
UAL) to evaluate treatment quality (Aim 1). Phase 2 is a
web-based survey of ASUD parents to establish the psy-
chometric properties of the PSQ measure (Aim 2) and
to elucidate the marketing preferences of the target
population (using the adapted Marketing Mix frame-
work, Aim 3). Phase 3 is a two-group, web-based RCT
comparing the effectiveness of targeted marketing mes-
sages versus standard clinical information in prompting
parents of ASUDs to seek information about EBP (Aim 4).
The RCT in Phase 3 is designed to test the hypotheses
that relative to parents who view standard clinical
information, parents of ASUDs who view targeted mar-
keting messages will demonstrate: 1) greater PSQ
ratings (as assessed using the new measure); 2) greater
reported behavioral intentions to seek out EBP; and 3)




Four key decisions were made related to study design.
First, this study focuses on EBP as a modality, rather
than on a specific therapy model. In the pharmaceutical
industry, investment in DTC marketing increased by 330
percent from 1996 to 2005 [56]. Analysis of this invest-
ment has unequivocally established that DTC marketing
can increase demand for both individual products (e.g.,
Prozac) and entire classes of products (e.g., selective-
serotonin reuptake inhibitors) [56]. Hence, developing
targeted marketing has the potential to stimulate cus-
tomer demand not only for individual therapy models, but
also for EBP as a class of treatment. Second, this studyear 2 Year 3 Year 4 Year 5
X
X X
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instead of ASUDs themselves. DTC marketing princi-
ples are most relevant for customers who select, initiate,
and finance a service [57]. Whereas in many disciplines
the customer who purchases the service is also the con-
sumer who uses the service, this is rarely the case for
ASUD treatment. It has been established that ASUDs
rarely seek treatment of their own volition [58] and that
parents are more likely than youth to make decisions
about treatment selection [59,60]. This study therefore
prioritizes parent (customer) feedback and augments it
with ASUDs (consumer) feedback in the formative
qualitative research phase. Third, study eligibility is
based on parental concern about the teen’s substance
use. Specifically, parent report of the teen’s behavior
must meet the clinical cutoff on a substance use screen.
Although parents often underestimate ASUD severity
[61], this study aims to understand factors that influ-
ence utilization of treatment. Because parents are more
likely than youth to select treatment, parent impres-
sions are viewed as more likely to drive demand for
service than objectively measured or self-reported levels
of adolescent use. Finally, recruitment targets parents of
ASUDs who have either not yet engaged in treatment
(e.g., high risk, nontreatment seeking) or who have pre-
sented to treatment voluntarily (e.g., not mandated by
juvenile justice), as these parents are likely to have the
most choice in service selection.
Participants
Parents of ASUDs, the target population for this study,
must meet the following criteria: 1) primary legal guard-
ian of a teenager aged 12 to 17 years; 2) able to speak
and read in English; 3) report significant concern about
their teen’s substance use, as determined by their re-
sponses to a brief screening tool (see Measures). Adoles-
cents automatically qualify if their parents meet the
aforementioned criteria. Exclusion criteria are minimal to
enhance generalizability and include factors that would
preclude participation in a 1–2 hour study session (e.g.,
acute psychosis, insufficient cognitive capacity, etc.). In
accordance with institutional IRB approval, parents pro-
vide informed consent, and adolescents (in Phase 1 only)
provide written assent.
In Phase 1, participants were recruited from treat-
ment sites in the northeast region of the United States
that provide services for ASUDs across the full con-
tinuum of care: one primary care clinic, one adolescent
mental health clinic, one ASUD outpatient program,
and one ASUD residential treatment program. In
Phases 2 and 3, recruitment at these clinics will be
supplemented with online recruitment methods. Par-
ticipant demographics are expected to be representa-
tive of the population in the northeast region. Basedon regional demographics and enrollment rates in
prior studies, the sample is expected to be 70 percent
white, 8 percent African American, 1 percent Asian
American, 1 percent American Indian, and 19 percent
“other” or multiracial. Ethnic composition is expected
to be 33 percent Hispanic. Parents are expected to be
at least 80 percent female, whereas adolescents are
expected to be 60 percent male.
Measures
In all three study phases, participants complete three
brief measures: 1) a basic socio-demographic form; 2) a
brief screen about parental substance use (NIDA-Quick
Screener [62]; and 3) the Global Appraisal of Individual
Needs–Short Screener (GAIN-SS, [63]). The GAIN-SS
is a well-validated screening tool that consists of four
5-item screeners: substance use disorders, internalizing
problems, externalizing problems, and criminal behavior.
Each screener has demonstrated internal consistency,
excellent sensitivity (over 90%) for identifying people
with a disorder, and excellent specificity (over 95%) for
ruling out people without a disorder [63]. A positive
response to one or more items in each sub-screener
indicates a moderate likelihood of a diagnosis or signifi-
cant problems. Prior to enrollment, parent responses to
the substance use disorder screener are used to deter-
mine eligibility. After enrollment, responses to all four
screeners are used to track the level of adolescent sub-
stance use and co-occurring problems within the sample.
Procedures: study phase 1 (Specific Aim 1)— months 1–22
Phase 1 consisted of separate focus groups and struc-
tured interviews with ASUDs (n = 23) and their parents
(n = 29). Data from this phase addresses study Aim 1 to
adapt the Marketing Mix framework and to develop a
PSQ measure to ensure their relevance to the marketing
of ASUD treatment.
Focus groups and interviews
Participants participated in either a focus group or in-
dividual interview, depending on participant preference
and recruitment flow. Focus groups enrolled four to six
participants and lasted 75–90 minutes, whereas indi-
vidual interviews lasted 45–60 minutes. Focus groups
were homogeneous with regard to level of care and
conducted separately for parents and ASUDs. A trained
facilitator with over 10 years of qualitative experience
led the discussions, and a co-facilitator attended the
focus groups to take notes. All discussions followed a
semistructured agenda covering fundamental market-
ing concepts [26], including the four elements of the
Marketing Mix, ideal treatment experience, and dimen-
sions of PSQ.
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Audio files from focus groups and interviews were tran-
scribed verbatim by the co-facilitator and cleaned by the
lead facilitator. Transcripts were entered into NVivo, a
qualitative data management program. Parent and ado-
lescent data will be analyzed separately using standard
qualitative analysis techniques, including open coding,
axial coding, marginal remarks, and memo writing [64].
A list of thematic codes will be developed, beginning
with codes based on the agendas, and augmented with
codes emerging from the data. Codes for parent data will
be identified first and supplemented by unique codes in
ASUD data. Two independent coders will double-code
25 percent of transcripts, aiming for an overall kappa
over .60.
A modified grounded theory approach will be used
to organize themes arising from discussions to assess
the relevance of the Marketing Mix and to determine
dimensions of PSQ [64]. Based on prior research on
service quality [30,41,49,53,65] and barriers to adoles-
cent utilization of EBP [59,60,66,67], we expect that di-
mensions of PSQ for ASUD treatment may include
reliability, responsiveness, access, competence, tangi-
bles, courtesy, integrity, attentiveness, communication,
credibility, comfort, empathy, caring, availability, se-
curity, assurance/trust, affordability, flexibility, perso-
nalization, treatment relevance, treatment compatibility,
treatment alliance, and convenience.
Within each of the identified dimensions, verbatim
comments will be used to create an initial pool of items
for a PSQ measure. Participant comments will also be
used to create a draft pool of targeted marketing mes-
sages highlighting the benefits of EBP. Messages will be
developed using participants’ comments about the ele-
ments of an ideal service experience, including refer-
ences to service attributes that most strongly influence
treatment selection. As an example, if parents report
that therapist flexibility is the most important service
attribute, the statement would emphasize that EBP can
be tailored to individual teens using specific words from
parents’ verbatim comments. Imbedding valued service
attributes into marketing materials has been shown to
increase customers’ intentions to seek out a specific
service [68].
Cognitive interviews
Cognitive interviews, a qualitative approach to question-
naire modification, will be conducted with an additional
six ASUDs and six ASUD parents to assess the relevance
and clarity of the adapted Marketing Mix and PSQ.
Interviews will use the respondent debriefing technique
[69] and last 60–75 minutes. Each interview will consist
of administration of the PSQ measure, followed by a
series of questions about the clarity and rationale ofdirections, the perceived meaning of each item, the ap-
propriateness of response options, and the overall rele-
vance of the measure. Targeted marketing messages
about EBP will be tested using the same methods.
Interviews will be recorded with DVR and transcribed
verbatim. Feedback will be aggregated by questionnaire
component (e.g., directions, items, response options) to
inform revisions.
Procedures: study phase 2 (Specific Aims 2 and 3)—months
23–42
Phase 2 uses a survey of parents of ASUDs (n = 400) to
serve two goals: 1) establish the psychometric properties
of the PSQ, and 2) elucidate the marketing preferences
of ASUD parents using the Marketing Mix framework.
Surveys are often used in marketing research to test ini-
tial qualitative findings using direct questions in larger,
more representative samples [26].
Survey construction
In addition to containing the measures used in Phase 1,
the survey will contain the PSQ and a series of questions
about service preferences (about 40 items). Items about
service preferences will be developed based on feedback
from Phase 1 and will cover each element of the Market-
ing Mix framework. An example of a question from the
“Place” component might be a multiple-choice item indi-
cating where parents prefer to receive their information
about ASUD treatment, with response options based on
the data from Phase 1. Also, parents will be asked to
rank-order their preferred targeted marketing messages
from Phase 1.
Sampling considerations
Several sampling frames were considered for the survey,
each of which had benefits and tradeoffs. First, a non-
probabilistic (or nonrandom) online survey was consid-
ered, as this approach is commonly used in marketing
research [70]. As noted in Zeithaml et al.’s best-selling
services marketing textbook [26], the benefits of online
surveys include: broader geographic representation; en-
hanced accuracy and completeness of answers; speed;
reduced costs; and streamlined data analysis. However,
this approach was ruled out due to concerns about se-
lection bias and limited coverage of individuals without
internet access [71]. Second, community-based recruit-
ment was contemplated, as this approach is common in
treatment research. Although this approach yields a
nonprobabilistic sample, it protects against some of the
concerns about the reach of an online sample by facili-
tating proactive recruitment of low-income and under-
represented populations. Finally, various methods to
recruit a probabilistic sample were considered, each of
which would require members of the target population
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This approach would involve random selection of par-
ticipants from a known sample of parents of ASUDs
through national registries, school rosters, or other
means. Although this approach would yield the largest
benefits in terms of representativeness, its execution
would require the largest investment of time and financial
resources. As such, probabilistic sampling was deemed
beyond the scope of this protocol, which was funded by
a Research Career Development Award (K23) and de-
signed to collect preliminary data sufficient to establish
proof of concept.
Based on the aforementioned considerations, the sur-
vey will use multimethod, single-mode sampling, com-
bining community-based and online recruitment. Within
each method, quota sampling will be used to promote
representativeness with regard to geography, race/ethni-
city, gender, and parent characteristics in order to more
closely approximate a probabilistic sample [72]. All
participants will be administered the survey using a
web-based browser to prevent confounds associated
with modality. The community sample will complete
the survey on a laptop during an in-person study ses-
sion, while the online sample will complete the survey
from a computer of their choosing. The online sample
will be restricted to the six-state New England area in
order to promote consistency with the community
sample. Reflecting the differential level of effort re-
quired, participants in the community will receive $50,
while those in the online sample will receive $25.
Online recruitment
One-quarter to one-half of the survey participants will
be recruited through the clinics used in Phase 1.
Remaining participants will be recruited online, using an
existing website of the American Psychological Associa-
tion’s (APA) Division 53 (Society of Clinical Child and
Adolescent Psychology). The website (http://www.effective-
childtherapy.com) contains pages specifically designed to
educate parents about EBP for adolescents with mental
health and/or substance use problems. Banners will be
placed on the Substance Abuse and Dependence page,
along with pages for two conditions that are highly
comorbid among ASUDs: Disruptive Behavior Problems
and Depression and Related Disorders. Based upon web-
page usage statistics at the time of this protocol submis-
sion, these three pages respectively received an average of
108, 712, and 354 unique hits per month. Combining
these data with national estimates of internet usage [73]
and prevalence rates of co-occurring problems among
ASUDs [74-76] leads to the conservative estimate that ap-
proximately 29–40 webpage visitors per month likely will
meet study eligibility criteria. Using another conservative
estimate that only 50 percent of visitors will likelyparticipate (due to repeat visitors, ineligibility, and lack of
interest), this study will set a recruitment target of four
parents per week. Quota sampling will be used to promote
equivalence across the online and community-based sam-
ples on key demographic (e.g., age, race/ethnicity, socio-
economic status, region) and clinical variables (parental
substance use, number of concerns about teen substance
use endorsed on the screener); if sample differences are
detected across the two sampling frames, a propensity
weighting approach will be used to balance the samples
[77] prior to merging the data.
Survey analysis
Descriptive statistics will be generated to summarize
responses for the market research questions. Additional
analyses will be conducted to test the psychometric
properties of the new PSQ, including its factor structure,
internal consistency, and validity (criterion, convergent,
and discriminant). Items with a high proportion of miss-
ing data will be eliminated to create a more parsimoni-
ous scale. The following analyses are planned: Factor
Structure. The target sample of 400 and expected ques-
tionnaire length of 20 items will enable analyses to be
conducted using both Exploratory Factor Analysis (EFA)
and Confirmatory Factor Analysis (CFA). EFA will be
conducted using principal component analysis as the
extraction method and promax as the rotation method.
CFA will be conducted to further assess the scale’s struc-
ture. Model fit will be evaluated using conventional-fit
indices, including RMSEA, CFI, and chi-square [78]. Re-
liability. Internal consistency for each scale will be cal-
culated using Cronbach’s alpha, with values exceeding .7
viewed as evidence of high internal consistency [79]. Cri-
terion Validity. Consistent with the initial SERVQUAL
validation [39], criterion validity will be tested using global
assessments of service expectations on a 10-point scale
(1 = poor, 10 = excellent). Convergent Validity. Loading
of scale items on their corresponding factors will be
examined to assess convergent validity. Discriminant
Validity. Discriminant validity will be tested by con-
straining each correlation between pairs of factors (one
at a time) to unity in the measurement model and re-
peating the CFA. If the constrained CFA increases chi-
square, it will support the distinctiveness of each scale’s
component dimensions.
Procedures: study phase 3 (Specific Aim 4)—months 43–60
Phase 3 will use a two-group RCT (n = 160) to evaluate
the effectiveness of targeted marketing versus standard
clinical information in increasing parent impressions of
PSQ and persuading parents of ASUDs to seek out in-
formation about EBP. Study hypotheses will be tested using
the PSQ, which was adapted and validated in Phases 1–2,
as well as behavioral indicators of information-seeking.
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and multimethod, single-mode approach as Phase 2.
Sample size and power
One meta-analysis of the effect size (ES) of marketing
campaigns on the proportion of customers inquiring
about or purchasing a service found an average ES of .20
across 133 studies [80]. Of note, only one of the 133
studies tested marketing for a health-care service, and
this study found a higher ES of .30. This ES is consistent
with results of a recent quasi-experimental study compar-
ing the effectiveness of a DTC campaign versus standard
clinical guidelines in predicting cervical cancer screenings
(d = .26) [81]. Assuming that awareness of the services
marketed in prior studies was higher than current aware-
ness of EBP, targeted marketing has the potential to pro-
duce larger ES in the current study. The target sample of
160 (n = 80 per group) will provide 71 percent power to
detect an ES of .4; 88 percent for an ES of .5; and 96 per-
cent for an ES of .6 [82]. Thus, the proposed sample size
will be adequate to detect a medium ES, which is appro-
priate for a study that aims to provide proof of concept.
Randomization
A computer-generated urn randomization procedure will
be used to retain random allocation, while balancing rela-
tive probabilities of assignment to treatment groups (urns).
Randomization will occur after participants complete the
eligibility screening and prior to the manipulation. Variables
added to the urn will include both parent (e.g., gender,
race/ethnicity, parent substance use) and ASUD character-
istics (e.g., number of concerns endorsed on the substance
use screener, history of substance use treatment).
Parents will be randomized to one of two conditions:
targeted marketing or standard clinical information. Par-
ents in the marketing condition will be presented with the
descriptions of EBP that were rated as most appealing in
Phase 2, whereas parents in the standard information con-
dition will review descriptions of EBP created for parents
by leading scientific organizations in our field such as the
National Institute on Drug Abuse (NIDA), Division 53 of
The Society of Clinical Child and Adolescent Psychology
(APA), and the Substance Abuse and Mental Health Ser-
vices Administration. A sample standard clinical informa-
tion message (from the APA Division 53 website) is: Some
treatment approaches have a strong backing in scientific
evidence and other treatments have less evidence support-
ing them. Therapists who use treatments based on science
use what is called “evidence-based practice…” Messages
will be balanced to ensure comparable number of words.
Data collection and measures
The trial and quantitative data collection will be admin-
istered with Ilume software, a program designed forresearch surveys that is frequently used by the investiga-
tive team and that minimizes the likelihood of missing
data. Baseline. In addition to the core set of measures, par-
ents will answer questions assessing EBP attitudes, aware-
ness, prior use, and intent to use (based on survey items
from Phase 2). Parents will then be presented with one of
two descriptions of EBP, depending on their random
assignment. Post-intervention. Parents will complete Likert-
scale ratings of the presented information in terms of its
relevance to their teen/family, appeal, believability, ease
of understanding, and amount of information conveyed.
Parents will then complete the PSQ measure and a
Behavioral Intentions Scale. After parents complete
these measures, they will view a message thanking them
for their participation. They will then see two links: 1) a
link to end the study session, and 2) a link to receive
more information about EBP service options for their
teenager. The proportion of parents clicking the link to
receive more information will be viewed as a secondary
indicator of intentions to seek out EBP.
Outcomes
Descriptive statistics will be generated to describe the
data. Mean comparisons will be used to test the hypoth-
esis that participants in the marketing condition will
have greater perceptions of service (as measured by the
PSQ). The hypotheses that participants will report greater
behavioral intentions to use EBP and will demonstrate
greater likelihood to request information about EBP will
be measured by group comparisons using continuous rat-
ings on the Behavioral Intentions Scale and a categorical
indicator of whether the participant actually requested
information, respectively. If group differences emerge in
these basic analyses, multiple regression models will test
whether the group differences persist when controlling
for pre-manipulation variables such as EBP attitudes,
EBP awareness, intentions to seek therapy, and readabil-
ity statistics generated on the messages. For all of the
hypotheses, exploratory analyses will be conducted to
evaluate potential moderators and mediators. Ethnicity/
race, gender, and treatment history will be tested as
potential moderators of group differences, and ratings
of the information (e.g., ease of understanding, believ-
ability) will be tested as potential mediators of outcome.
In addition, for the hypotheses about behavioral indica-
tors (e.g., Behavioral Intentions Scales and likelihood of
requesting information), PSQ ratings will be examined
as potential mediators of outcome. These analyses will
be conducted to observe trends and highlight directions
for further research.
Discussion
The current study addresses an issue of importance to
our field and our nation’s public health: increasing the
Becker Addiction Science & Clinical Practice  (2015) 10:4 Page 9 of 10utilization of EBP by ASUDs. While prior studies have
worked to increase the utilization of EBP by targeting
treatment providers, this study evaluates the relevance
of DTC marketing to deliver information directly to par-
ents of ASUDs. Qualitative data collection from ASUDs
and their parents will be used to evaluate the utility of
the Marketing Mix framework in developing targeted
messages and to develop a new measure of PSQ, a key
construct in predicting demand for a service. A subse-
quent targeted survey will be used to further evaluate
the Marketing Mix and to validate the PSQ measure.
The final phase of the study will test the hypotheses
that targeted marketing messages developed using the
Marketing Mix framework, which will be associated
with greater perceptions of service quality (using the
PSQ measure) and greater behavioral intentions to
seek out information about EBP than standard clinical
information. Results of this study will have the poten-
tial to immediately inform DTC marketing efforts by
professional organizations, federal agencies, clinicians,
and clinical researchers.
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